Inicio › Afecciones posteriores al COVID-19 (COVID-19 persistente) › Georgia
Ensayos clínicos de Afecciones posteriores al COVID-19 (COVID-19 persistente) en Georgia
11 estudios sobre Afecciones posteriores al COVID-19 (COVID-19 persistente) buscan participantes en Georgia.
Ciudades en Georgia
Texto oficial del estudio (inglés)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Balanced Life Health Care Solutions/SKYCRNG ( Site 3713), Lawrenceville
- Renew Health Clinical Research ( Site 3760), Snellville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06667700A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- The Hope Clinic of Emory University, Decatur
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 64 · Todos los sexos · Actualizado el 2 oct 2026 · NCT07536308A Study of COVID-19 Vaccine(s) in Children and Adults
- AGILE Clinical Research Trials, LLC, Atlanta
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 5 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Velocity Clinical Research, Savannah, Savannah
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Emory University, Atlanta
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- The Hope Clinic of Emory University, Decatur
- Javara - Privia Medical Group Georgia - Fayetteville, Fayetteville
- Coastal Heritage Clinical Research, Hinesville
- y 1 más
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Stockbridge
ReclutandoFase 1
Edades de 65 a 85 · Todos los sexos · Actualizado el 30 jun 2026 · NCT07464314Arginine Replacement Therapy in COVID-19
- Children's Healthcare of Atlanta (CHOA), Arthur M. Blank, Atlanta
ReclutandoFase 2
Edades de 3 a 21 · Todos los sexos · Actualizado el 15 abr 2026 · NCT05855330A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- CenExel, Atlanta
- CenExel, Decatur
ReclutandoFase 4Se aceptan voluntarios sanos
6 Months · Todos los sexos · Actualizado el 27 mar 2026 · NCT06585241EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
ReclutandoFase 3
Edades de 0 a 17 · Todos los sexos · Actualizado el 17 jul 2025 · NCT05261139Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Augusta University, Augusta
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jul 2024 · NCT02735707De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.